{name}
{subtitle}
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~12 mi. (Elizabeth Vale, Australia, +144 more cities)
facility
Lyell McEwin Hospital ( Site 4004)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
city
~12 mi. (Elizabeth Vale, Australia, +247 more cities)
facility
Calvary Central Districts Hospital
biomarker
ER Positive, +1 more biomarker
drug
anthracycline, +4 more drugs
drug type
chemotherapy, +2 more types
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
city
~12 mi. (Elizabeth Vale, Australia, +93 more cities)
facility
Lyell McEwin Hospital ( Site 1252)
condition
Bladder Carcinoma, +1 more condition
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +3 more types
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
city
~12 mi. (Elizabeth Vale, Australia, +145 more cities)
facility
Calvary Central Districts Hospital
drug
ipilimumab, +1 more drug
Tislelizumab Plus BGB-A1217 Versus Tislelizumab Versus Durvalumab When Co-administered With Concurrent Chemoradiotherapy (cCRT) in Lung Cancer
city
~12 mi. (Elizabeth Vale, Australia, +7 more cities)
facility
Lyell McEwin Hospital
drug
chemotherapy, +3 more drugs
drug type
chemotherapy, +1 more type
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
city
~12 mi. (Elizabeth Vale, Australia, +78 more cities)
facility
Local Institution
drug
ipilimumab, +3 more drugs
drug type
immunotherapy, +1 more type
Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment
city
~12 mi. (Elizabeth Vale, Australia, +36 more cities)
facility
Cavalry Central Districts Hospital
drug
pembrolizumab, +1 more drug
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
city
~27 mi. (Woodville, Australia, +141 more cities)
facility
GSK Investigational Site
drug type
chemotherapy, +1 more type